Literature DB >> 16641476

Activity of novel benzoxazinorifamycins against rifamycin-resistant Streptococcus pyogenes.

Steve Mullin, David M Rothstein, Christopher K Murphy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16641476      PMCID： PMC1472231          DOI： 10.1128/AAC.50.5.1908-1909.2006

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  12 in total

1.  Rifampin resistance in Streptococcus pyogenes.

Authors:  L Herrera; C Salcedo; B Orden; B Herranz; R Martinez; A Efstratiou; J A Sáez Nieto
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2002-05-17       Impact factor: 3.267

2.  rpoB mutations in Streptococcus mitis clinical isolates resistant to rifampin.

Authors:  Wafa Achour; Olfa Guenni; Marguerite Fines; Roland Leclercq; Assia Ben Hassen
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

3.  Molecular basis of rifampin resistance in Streptococcus pneumoniae.

Authors:  T Padayachee; K P Klugman
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

4.  New mutations and horizontal transfer of rpoB among rifampin-resistant Streptococcus pneumoniae from four Spanish hospitals.

Authors:  María José Ferrándiz; Carmen Ardanuy; Josefina Liñares; José María García-Arenzana; Emilia Cercenado; Ana Fleites; Adela G de la Campa
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

5.  Low-level resistance to rifampin in Streptococcus pneumoniae.

Authors:  Patricia Stutzmann Meier; Silvia Utz; Suzanne Aebi; Kathrin Mühlemann
Journal:  Antimicrob Agents Chemother       Date:  2003-03       Impact factor: 5.191

6.  Correlation between in vivo and in vitro efficacy of antimicrobial agents against foreign body infections.

Authors:  A F Widmer; R Frei; Z Rajacic; W Zimmerli
Journal:  J Infect Dis       Date:  1990-07       Impact factor: 5.226

7.  Mutations of the rpoB gene in rifampicin-resistant Streptococcus pneumoniae in Taiwan.

Authors:  J-Y Chen; Chang-Phone Fung; Feng-Yee Chang; Li-Yueh Huang; Jen-Chang Chang; L K Siu
Journal:  J Antimicrob Chemother       Date:  2004-01-16       Impact factor: 5.790

8.  In vitro activity of novel rifamycins against rifamycin-resistant Staphylococcus aureus.

Authors:  Christopher K Murphy; Steve Mullin; Marcia S Osburne; John van Duzer; Jim Siedlecki; Xiang Yu; Kathy Kerstein; Michael Cynamon; David M Rothstein
Journal:  Antimicrob Agents Chemother       Date:  2006-03       Impact factor: 5.191

Review 9.  Pharmacokinetics and metabolism of rifampin in humans.

Authors:  G Acocella
Journal:  Rev Infect Dis       Date:  1983 Jul-Aug

10.  Characterization of mutations in the rpoB gene that confer rifampin resistance in Staphylococcus aureus.

Authors:  H Aubry-Damon; C J Soussy; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1998-10       Impact factor: 5.191
View more
  1 in total

1.  Efficacy of novel rifamycin derivatives against rifamycin-sensitive and -resistant Staphylococcus aureus isolates in murine models of infection.

Authors:  David M Rothstein; Ronald S Farquhar; Klari Sirokman; Karen L Sondergaard; Charles Hazlett; Angelia A Doye; Judith K Gwathmey; Steve Mullin; John van Duzer; Christopher K Murphy
Journal:  Antimicrob Agents Chemother       Date:  2006-08-28       Impact factor: 5.191
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.